ECTRIMS eLearning

Disease activity and depression in multiple sclerosis correspond with glutamate-induced disturbances of hypothalamus - 1H magnetic resonance spectroscopy study
Author(s): ,
E Kantorová
Affiliations:
Clinic of Neurology
,
H Poláček
Affiliations:
Clinic of Nuclear Medicine
,
M Bittšanský
Affiliations:
BioMed
,
E Baranovičová
Affiliations:
BioMed
,
P Hnilicová
Affiliations:
BioMed
,
S Sivák
Affiliations:
Clinic of Neurology
,
V Nosáľ
Affiliations:
Clinic of Neurology
,
K Zeleňák
Affiliations:
Clinic of Radiodiagnostics
,
D Čierny
Affiliations:
Department of Clinical Biochemistry, Jessenius Faculty of Medicine, Comenius University Bratislava, Martin, Slovakia
,
D Dobrota
Affiliations:
Department of Clinical Biochemistry, Jessenius Faculty of Medicine, Comenius University Bratislava, Martin, Slovakia
E Kurča
Affiliations:
Clinic of Neurology
ECTRIMS Learn. Kantorova E. 09/14/16; 145539; EP1443
Ema Kantorova
Ema Kantorova
Contributions
Abstract

Abstract: EP1443

Type: ePoster

Abstract Category: Pathology and pathogenesis of MS - Imaging

Introduction: Disturbances of the hypothalamo-pituitary (HPA) axis are supposed to be involved into pathogenesis of multiple sclerosis (MS). Moreover, the HPA connections with limbic system and frontal cortex can cause depression, frequently reported phenomenon associated with multiple sclerosis (MS).

Method: We focused on in-vivo evaluation of hypothalamic metabolism via 1H- MR spectroscopy (1H-MRS) in 33 MS patients with relapsing-remitting and secondary progressive disease, and 24 age and sex- related healthy individuals (CON). Concentrations of glutamate+glutamin (Glx), cholin (Cho), myoinositol (mIns), N-acetyl aspartate (NAA) expressed as ratio with creatine (Cr) and N-acetyl aspartate (NAA) were correlated with Simple Depressive-Severity Status Scale (SDSS). In MS patients relationship of metabolites with disease activity using RIO score and with Multiple Sclerosis Severity Scale (MSSS) was evaluated.

Results: Glutamate was the only metabolite correlated with MS activity (Glx/Cr with mRIO=0 vs Glx/Cr with mRIO>=1: p = 0.005 // Glx/NAA with mRIO=0 vs Glx/NAA with mRIO>=1: p = 0.00018. Mann-Whitney). We found also association of glutamate concentrations and MSSS (Glx/Cr: r=0.4, p=0.02, Glx/NAA: r=0.56, p=0.001 Spear). In MS patients depressive score correlated with increased glutamate concentrations (SDSS vs Glx/Cr: r = -0.33, p = 0.028, Glx/NAA: r = -0.33, p = 0.08 Spear).

In CON Glx correlated with age (Glx/Cr: r = -0.42, p = 0.048, Glx/NAA: r = -0.41, p = 0.056 Spearman), but a relationship of Glx and SDSS was not proved.

Conclusion: Glutamate-induced damage of hypothalamus reflects activity and also severity of the disease. Depression appears to be rather symptom of MS than comorbid disease. In healthy individuals we proved age-related changes of Glx. It is a first study revealing the relationship of depression, disease activity and hypothalamic metabolism in MS.

This work was supported by VEGA 1/0287/16.

Disclosure: Authors confirm that there are no known conflict of interest associated with this work. There has been no significant financial support for this work that could have influenced its outcome.

Ema Kantorova, Hubert Polacek, Michal Bittšanský, Eva Baranovičová, Petra Hnilicova, Daniel Čierny, Stefan Sivák, Vladimir Nosal, Kamil Zelenak, Dusan Dobrota, Egon Kurca have nothing to disclose

Abstract: EP1443

Type: ePoster

Abstract Category: Pathology and pathogenesis of MS - Imaging

Introduction: Disturbances of the hypothalamo-pituitary (HPA) axis are supposed to be involved into pathogenesis of multiple sclerosis (MS). Moreover, the HPA connections with limbic system and frontal cortex can cause depression, frequently reported phenomenon associated with multiple sclerosis (MS).

Method: We focused on in-vivo evaluation of hypothalamic metabolism via 1H- MR spectroscopy (1H-MRS) in 33 MS patients with relapsing-remitting and secondary progressive disease, and 24 age and sex- related healthy individuals (CON). Concentrations of glutamate+glutamin (Glx), cholin (Cho), myoinositol (mIns), N-acetyl aspartate (NAA) expressed as ratio with creatine (Cr) and N-acetyl aspartate (NAA) were correlated with Simple Depressive-Severity Status Scale (SDSS). In MS patients relationship of metabolites with disease activity using RIO score and with Multiple Sclerosis Severity Scale (MSSS) was evaluated.

Results: Glutamate was the only metabolite correlated with MS activity (Glx/Cr with mRIO=0 vs Glx/Cr with mRIO>=1: p = 0.005 // Glx/NAA with mRIO=0 vs Glx/NAA with mRIO>=1: p = 0.00018. Mann-Whitney). We found also association of glutamate concentrations and MSSS (Glx/Cr: r=0.4, p=0.02, Glx/NAA: r=0.56, p=0.001 Spear). In MS patients depressive score correlated with increased glutamate concentrations (SDSS vs Glx/Cr: r = -0.33, p = 0.028, Glx/NAA: r = -0.33, p = 0.08 Spear).

In CON Glx correlated with age (Glx/Cr: r = -0.42, p = 0.048, Glx/NAA: r = -0.41, p = 0.056 Spearman), but a relationship of Glx and SDSS was not proved.

Conclusion: Glutamate-induced damage of hypothalamus reflects activity and also severity of the disease. Depression appears to be rather symptom of MS than comorbid disease. In healthy individuals we proved age-related changes of Glx. It is a first study revealing the relationship of depression, disease activity and hypothalamic metabolism in MS.

This work was supported by VEGA 1/0287/16.

Disclosure: Authors confirm that there are no known conflict of interest associated with this work. There has been no significant financial support for this work that could have influenced its outcome.

Ema Kantorova, Hubert Polacek, Michal Bittšanský, Eva Baranovičová, Petra Hnilicova, Daniel Čierny, Stefan Sivák, Vladimir Nosal, Kamil Zelenak, Dusan Dobrota, Egon Kurca have nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies